Farzaad Abdi-Dezfuli
Director/Board Member at APIM Therapeutics AS
Profile
Farzaad Abdi-Dezfuli is currently a Director at APIM Therapeutics AS and a Partner at Sarsia Seed Management AS.
Previously, he worked as a Director at Coegin Pharma.
AS and as a Team Leader at Eli Lilly & Co. and Eli Lilly Norge AS.
He holds a doctorate degree from The University of Edinburgh.
Farzaad Abdi-Dezfuli active positions
| Companies | Position | Start |
|---|---|---|
Sarsia Seed Management AS
 Sarsia Seed Management AS Investment ManagersFinance Sarsia Seed Management AS is a venture capital firm headquartered in Bergen, Norway. The company was founded in 2006. | Private Equity Investor | 2006-08-31 |
APIM Therapeutics AS
 APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | Director/Board Member | - |
Former positions of Farzaad Abdi-Dezfuli
| Companies | Position | End |
|---|---|---|
Eli Lilly Norge AS
 Eli Lilly Norge AS Medical DistributorsDistribution Services Eli Lilly Norge AS engages in the provision of pharmaceutical products and services. Its commodities were developed for the treatment of diabetes, cardiovascular diseases, cancer, nervous system, osteoporosis, psoriasis, rheumatology, urology, and growth failure. The company was founded in 1976 and is headquartered in Oslo, Norway. | Corporate Officer/Principal | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Coegin Pharma AS
 Coegin Pharma AS Pharmaceuticals: MajorHealth Technology Coegin Pharma AS provides therapeutics that addresses inflammatory diseases. The company was founded by Berit Johansen on January 3, 2005 and is headquartered in Trondheim, Norway. | Director/Board Member | - |
Training of Farzaad Abdi-Dezfuli
| The University of Edinburgh | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| Private companies | 4 |
|---|---|
Sarsia Seed Management AS
Sarsia Seed Management AS Investment ManagersFinance Sarsia Seed Management AS is a venture capital firm headquartered in Bergen, Norway. The company was founded in 2006. | Finance |
Coegin Pharma AS
Coegin Pharma AS Pharmaceuticals: MajorHealth Technology Coegin Pharma AS provides therapeutics that addresses inflammatory diseases. The company was founded by Berit Johansen on January 3, 2005 and is headquartered in Trondheim, Norway. | Health Technology |
APIM Therapeutics AS
APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway. | Health Technology |
Eli Lilly Norge AS
Eli Lilly Norge AS Medical DistributorsDistribution Services Eli Lilly Norge AS engages in the provision of pharmaceutical products and services. Its commodities were developed for the treatment of diabetes, cardiovascular diseases, cancer, nervous system, osteoporosis, psoriasis, rheumatology, urology, and growth failure. The company was founded in 1976 and is headquartered in Oslo, Norway. | Distribution Services |
- Stock Market
- Insiders
- Farzaad Abdi-Dezfuli
